Tocolysis - Indication, Contraindications, and Clinical Significance

Introduction:

Tocolysis is an obstetrical technique that prolongs gestation in patients in preterm labor by administering a variety of drugs that block uterine smooth muscle contractions. These drugs are given to lower fetal morbidity and mortality. Tocolysis is meant to prolong pregnancy for two to seven days and operates by producing a stable environment in the uterus.

The World Health Organization (WHO) defines a preterm delivery as a live birth occurring before 37 weeks of gestation. In 2014, the global preterm birth rate was estimated at 14.84 million newborns. Preterm birth problems are the leading cause of mortality in children under the age of five. Yet, the vast majority of these deaths may be avoided with universal access to high-quality maternal and preterm newborn care. Tocolysis is successful because it works to both delay and weaken uterine contractions.

Pharmacology focuses on myometrial action. Myometrium is the uterine smooth muscle. Though the typical gestational age for women to go into labor is 40 weeks, various factors can cause labor to begin earlier. Preterm birth is divided into three groups depending on gestational age: extremely premature (<28 weeks), severe premature (28 to 32 weeks), and moderate to late premature (32 to 37 weeks). A shift in the balance of anti-inflammatory and proinflammatory cytokines mediates the transition to a contractional uterus.

Uterine overdistention, anxiety, illness, vascular problems, and decidual aging can all cause preterm labor. If contractions start too early, the fetus has a low probability of survival. Among these groups, preterm neonates have the highest rates of morbidity and mortality, with more than 90 % of these infants dying in low-income countries with few resources. Although the majority of premature deliveries do not have an apparent risk factor, some can be attributable to medical disorders and pregnancy difficulties. More than one pregnancy and growth-restricted fetuses have been identified as high-risk factors for preterm birth, with more excellent rates of perinatal morbidity and mortality than normal pregnancies.

What Are the Indications of Tocolysis in Pregnancy?

Tocolysis is utilized in cases of premature labor. Preterm birth occurs before 37 weeks of gestation or following 20 weeks. Continued contractions during the previously specified gestational age range induce cervical changes, which can be used to detect premature labor. Predicting which individuals in preterm labor will have a preterm delivery is difficult. Tocolysis is effective for people experiencing preterm labor before 34 weeks of pregnancy. Tocolytic medicines are not considered prophylactic because they have not been proven to lower newborn morbidity.

Tocolysis has also been employed in cases of external cephalic version, uterine tachysystole, and fetal distress. A 0.25 mg dosage of Terbutaline is administered subcutaneously or intravenously 30 minutes before the surgery.

Terbutaline delivery via subcutaneous or intravenous routes is identical. Uterine tachysystole is characterized as more than five contractions per 10 minutes, averaged over 30 minutes. Betamimetics, such as Terbutaline, are helpful in stopping uterine contractions in this emergency.

What Are the Contraindications of Tocolysis in Pregnancy?

Contraindications for tocolysis include:

• A gestational age over 34 weeks.

• Intrauterine fetal death.

• Preterm premature rupture of membranes (unless there is no evidence of maternal illness and there is a need for transportation, steroid medication, or both).

• Specific contraindications for tocolytic agents.

• Lethal fetal anomaly.

• Non-reassuring fetal conditions can indicate severe preeclampsia or eclampsia.

• Maternal bleeding and hemodynamic instability.

• Chorioamnionitis.

• Advanced cervical dilatation exceeds 5 cm.

• Maternal cardiovascular disease.

• Hyperthyroidism.

• Diabetes that is not under control.

• Mild abruptio placentae.

• Persistent placenta previa.

• Intrauterine development limitation.

How Is Tocolysis Done?

Tocolysis is accomplished through various methods, all with the same goal of reducing smooth muscle contractions in the uterus. Different tocolytic drugs are preferred according to the mother's medical history, present gestational age, and cost. Furthermore, combined tocolytic therapy may be more successful than single tocolytic agents. Repeated tocolytic treatment is not indicated.

The following drugs are currently used:

• Magnesium Sulfate - Magnesium sulfate has an uncertain mode of action in uterine contractions, but it has been shown to prevent calcium entrance into the uterine smooth muscle. It also has vasodilating properties on uterine blood arteries. Magnesium sulfate should not be used in conjunction with calcium channel-blocking medications unless for neuroprotection due to the danger of maternal respiratory depression.

• Beta-adrenergic Receptor Agonists - Beta-adrenergic receptor agonists specifically target the beta-2 receptor. Activation of the beta-2 receptors increases cyclic AMP (cAMP), which is related to greater smooth muscle relaxation.

• Oxytocin Inhibitors - Oxytocin inhibitors function by competing at the oxytocin receptor site. Oxytocin increases intracellular levels of inositol triphosphate. Atosiban and Retosiban are the current drugs in this class.

• Calcium Channel Blockers - Calcium channel blockers specifically target T-type calcium channels, blocking calcium entrance into the uterine smooth muscle. A shortage of free calcium directly affects the ability of calcium-calmodulin to activate myosin light chain kinase. The most often used medicine in this class is Nifedipine.

• Nonsteroidal Anti-Inflammatory Drug - Nonsteroidal anti-inflammatories function by blocking cyclooxygenases. These enzymes produce prostaglandins from arachidonic acid.

What Is the Clinical Significance of Tocolysis?

Tocolysis is an emergency technique used to lengthen gestation and reduce fetal morbidity and mortality. Tocolysis is therapeutically significant since it increases the time required to undertake newborn procedures. The World Health Organization has demonstrated that delaying delivery by up to 48 hours allows prenatal corticosteroids to aid fetal lung maturation in premature newborns.

Conclusion:

Tocolysis using an effective pharmacological drug can diminish, stop, or slow uterine contractions in women who suffer spontaneous premature labor. Several medications can postpone childbirth by two to seven days. Although trial evidence suggests that these drugs provide no independent benefits for improving substantive perinatal health outcomes, they can be used as a temporary measure for administering antenatal corticosteroids to accelerate fetal lung maturity or to transfer a woman in preterm labor to a higher level of care.